FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic

FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic

The prevalence of obesity or metabolic syndrome is increasing worldwide (globally metabodemic). Approximately 25% of the adult general population is suffering from nonalcoholic fatty liver disease (NAFLD), which has become a serious health problem. In 2020, global experts suggested that the nomencla...

Full description

Bibliographic Details
Main Authors:	Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, Miwa Kawanaka, Hideki Fujii, Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuichiro Eguchi, Masafumi Ono, Yuichi Nozaki, Hideyuki Hyogo, Masahiro Koseki, Yuichi Yoshida, Takumi Kawaguchi, Yoshihiro Kamada, Takeshi Okanoue, Atsushi Nakajima, Japan Study Group of NAFLD (JSG-NAFLD)
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	Life
Subjects:	hepatic fibrosis hepatocellular carcinoma vibration-controlled transient elastography nonalcoholic fatty liver disease type 2 diabetes metabolic-dysfunction-associated fatty liver disease
Online Access:	https://www.mdpi.com/2075-1729/11/2/143

Similar Items

Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis
by: Yoshio Sumida, et al.
Published: (2020-03-01)

Fatty Liver, and Not Visceral Fat, Is More Associated with Liver Fibrosis and Diabetes in Non-Obese Japanese Individuals: A Cross-Sectional Study
by: Noriyo Urata, et al.
Published: (2020-09-01)

The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan
by: Yuya Seko, et al.
Published: (2020-10-01)

Nonalcoholic fatty liver disease in Hong Kong Chinese.
Published: (2009)

The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma
by: Tomomi Kogiso, et al.
Published: (2021-01-01)

FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease
by: Yuya Seko, et al.
Published: (2019-12-01)

Value of screening for nonalcoholic fatty liver disease in hyperuricemic patients with normal body mass index by two-dimensional ultrasound: Upper Egypt experience
by: Amro M Hassan, et al.
Published: (2020-01-01)

Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees
by: Kenichiro Murayama, et al.
Published: (2021-01-01)

Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Non-Alcoholic Fatty Liver: A Systematic Review and Meta-Analysis
by: Cheng-Han Lee, et al.
Published: (2020-09-01)

Quantitative ultrasound radiofrequency data analysis for the assessment of hepatic steatosis using the controlled attenuation parameter as a reference standard
by: Sun Kyung Jeon, et al.
Published: (2021-01-01)

Liver regeneration in nonalcoholic fatty liver disease
by: Aldo Lagomarsino
Published: (2012-12-01)

Effect of essential fatty acid deficiency on release of triglycerides by the perfused rat liver
by: TOSHIO FUKAZAWA, et al.
Published: (1970-11-01)

Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study
by: Yasushi Honda, et al.
Published: (2017-08-01)

Comparison of liver enzymes and sonological grading in nonalcoholic fatty liver
by: Bishnu Jwarchan, et al.
Published: (2020-03-01)

Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
by: Yen-Ying Chen, et al.
Published: (2021-01-01)

<b>Analytical methods for evaluation of the fatty acid metabolism in rat liver
by: Eduardo Hideo Gilglioni, et al.
Published: (2018-11-01)

The fatty liver index (FLI) and incident hypertension: a longitudinal study among Chinese population
by: Kena Zhou, et al.
Published: (2018-09-01)

Correlational study of nonalcoholic fatty liver disease diagnosed by ultrasonography with lipid profile and body mass index in adult nepalese population
by: Umesh P Khanal, et al.
Published: (2019-01-01)

Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1 s⃞
by: Gizem Rizki, et al.
Published: (2006-10-01)

FIB-4 Regression With Direct-Acting Antiviral Therapy in Patients With Hepatitis C Infection: A Safety-Net Hospital Experience
by: Sara Ghoneim, et al.
Published: (2020-07-01)

Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
by: Yasushi Honda, et al.
Published: (2020-06-01)

Evaluation of Liver Stiffness in Healthy Individuals by Sonoelastography
by: VEERENDRA KUMAR SHARMA, et al.
Published: (2017-11-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Impact of variations in fatty liver on sonographic detection of focal hepatic lesions originally identified by CT
by: Size Wu, et al.
Published: (2016-01-01)

Kinetics of the inflammatory response induced by free fatty acid accumulation in hepatocytes
by: Norberto C. Chávez-Tapia, et al.
Published: (2014-01-01)

Evidence-Based Aerobic Exercise Training in Metabolic-Associated Fatty Liver Disease: Systematic Review with Meta-Analysis
by: Joanna Słomko, et al.
Published: (2021-04-01)

Multinodular fatty liver after herpes-zoster vaccine: Case report and review of the literature
by: Michael Shim, et al.
Published: (2008-10-01)

Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function
by: Ji Taek Hong, et al.
Published: (2021-03-01)

Significant Burden of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Iranian Population: A Cross-Sectional Analysis
by: Behnam Hosseini Ahangar, et al.
Published: (2020-05-01)

Knowing what’s out there: awareness of Non Alcoholic Fatty Liver Disease.
by: Vishal eGhevariya, et al.
Published: (2014-03-01)

Nonalcoholic steatohepatitis in posttransplantation liver: Review article
by: Antônio Ricardo Cardia Ferraz de Andrade, et al.

Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
by: Karn Wijarnpreecha, et al.
Published: (2021-04-01)

Performance of Fatty Liver Index in Identifying Non-Alcoholic Fatty Liver Disease in Population Studies. A Meta-Analysis
by: Marco Castellana, et al.
Published: (2021-04-01)

Advancing the global public health agenda for NAFLD: a consensus statement
by: Åberg, F., et al.
Published: (2022)

Fatty liver: How frequent is it and why?
by: Giorgio Bedogni, et al.
Published: (2004-04-01)

Links between gut microbiome composition and fatty liver disease in a large population sample
by: Matti O. Ruuskanen, et al.
Published: (2021-01-01)

Nonalcoholic steatohepatitis Fitness Intervention in Thrombosis (NASHFit): Study protocol for a randomized controlled trial of a supervised aerobic exercise program to reduce elevated clotting risk in patients with NASH
by: Jonathan G. Stine, et al.
Published: (2020-06-01)

A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid
by: V.N. Santos, et al.
Published: (2003-06-01)

Breastfeeding duration and reduced risk of NAFLD in midlife of parous women
by: Alessandro Mantovani, et al.
Published: (2021-10-01)

Risk factors and predictors of non-alcoholic fatty liver disease in Taiwan
by: Ying-Chin Lin, et al.
Published: (2011-04-01)